ReviewJournal of cutaneous pathology2026
Eccrine Squamous Syringometaplasia Mimicking Acute Cutaneous GVHD in a Pediatric HSCT Recipient: Case Report and Brief Review of the Indexed Literature.
Review in Journal of cutaneous pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Eccrine squamous syringometaplasia (ESS) is an uncommon reactive alteration of eccrine ducts, most often reported in oncologic and transplant settings, where it may clinically mimic acute cutaneous graft-versus-host disease (GVHD). We describe a 3-year-old boy with chronic granulomatous disease who developed a diffuse erythematous eruption 6 weeks after haploidentical hematopoietic stem cell transplantation. Clinically suggestive of acute GVHD, histopathologic examination instead revealed spongiotic dermatitis with prominent squamous metaplasia of eccrine ducts, in the absence of interface dermatitis, keratinocyte apoptosis, or satellitosis, supporting a diagnosis of ESS. The eruption resolved with topical corticosteroids without modification of systemic therapy. We also provide a brief review of Scopus/PubMed-indexed literature, summarizing reported clinical settings, triggers, histopathologic features, and outcomes. Clinicopathologic correlation is essential in transplant recipients to distinguish ESS from GVHD and to avoid unnecessary escalation of immunosuppression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.